| Ytd | 65.07% | |
| 1y | 296.55% |
| Open | 7.08 | Prev Close | 7.00 | Low | 6.75 | High | 7.10 | Mkt Cap | 2.46B |
| Vol | 3.14M | Avg Vol | 5.16M | EPS | -0.09 | P/E | -76.72 | Forward P/E | -32.86 |
| Beta | 1.02 | Short Ratio | 7.93 | Inst. Own | 72.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 5.25 | 200-d Avg | 4.37 | 1yr Est | 14.50 |
Precigen surged 266% on PAPZIMEOS FDA approval but now trades at a premium valuation near $2.24 bill
Precigen, Inc. is upgraded to a Strong Buy, driven by surging PAPZIMEOS revenues and FDA approval fo
Arrowstreet Capital Limited Partnership acquired a new stake in shares of Precigen, Inc. (NASDAQ: PG
Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP
Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares
Precigen, Inc. (PGEN) Q2 2026 Earnings Call Transcript
Precigen NASDAQ: PGEN reported a sharp increase in second-quarter revenue from its PAPZIMEOS launch,
Precigen, Inc. (PGEN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consens
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'
PAPZIMEOS ® net revenue of $53.1 million in the second quarter of 2026, more than double the prior q
GERMANTOWN, Md., July 21, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage bio
CFO Harry Thomasian Jr. sold 200,000 shares of Precigen common stock across two transactions for a t
Precigen earns a STRONG BUY rating following the commercial success of PAPZIMEOS and rapid revenue g
Meg Flippin, Benzinga Staff Writer Data reviewed by Dr. Helen Sabzevari at last week's Goldman Sachs
41,884 shares were sold in an open-market transaction for a total of ~$183,000 on May 28, 2026. The
Third annual RRP Awareness Day highlights the experiences of people living with recurrent respirator
Precigen, Inc. (PGEN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc
Does Precigen, Inc. (PGEN) have what it takes to be a top stock pick for momentum investors? Let's f
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Ex
15 out of 18 complete responders, or 83%, demonstrated ongoing complete responses for at least 36 mo
FDA grants orphan drug exclusivity for PAPZIMEOS for the treatment of adults with recurrent respirat
GERMANTOWN, Md., May 26, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biop
Precigen, Inc. delivered $21.6M in Q1 Papzimeos revenue, aligning with bullish expectations but leav
Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. S
Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results.
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) rose sharply in today’s pre-market trading after the
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn
Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for
Gainers
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
On Friday, 1043 companies hit new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.